Marcel Rozencweig, M.D.

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial
Sternberg, Cora N; Petrylak, Daniel P; Sartor, Oliver; Witjes, J Alfred; Demkow, Tomasz; Ferrero, Jean-Marc; Eymard, Jean-Christophe; Falcon, Silvia; Calabro, Fabio; James, Nicholas; Bodrogi, Istvan; Harper, Peter; Wirth, Manfred; Berry, William; Petrone, Michael E; McKearn, Thomas J; Noursalehi, Mojtaba; George, Martine; Rozencweig, Marcel
2009 Nov 10;27(32):5431-5438, Journal of clinical oncology
— id: 143406, year: 2009, vol: 27, page: 5431, stat: Journal Article,

[Cancer therapy--economic aspects]
Catane, R; Catane, H; Rozencweig, M
1995 Feb;128(3):182-185, Harefuah: journal of the Israeli Medical Association
— id: 162341, year: 1995, vol: 128, page: 182, stat: Journal Article,

Relation between plasma concentrations of didanosine and markers of antiviral efficacy in adults with AIDS or AIDS-related complex
Beltangady, M; Knupp, C A; Gustafson, N; Barbhaiya, R H; Dolin, R; Seidlin, M; Cooley, T P; Rozencweig, M
1993 Feb;16 Suppl 1:S26-S31, Clinical infectious diseases
— id: 162343, year: 1993, vol: 16 Suppl 1, page: S26, stat: Journal Article,

Longitudinal analysis of responses to oral didanosine therapy following zidovudine therapy in advanced infection with human immunodeficiency virus
McLaren, C; Rozencweig, M; Beltangady, M; Nicaise, C; Yarchoan, R; Dolin, R; Allan, J D; Cooley, T P; Seidlin, M; Smaldone, L F
1993 Feb;16 Suppl 1:S32-S39, Clinical infectious diseases
— id: 162342, year: 1993, vol: 16 Suppl 1, page: S32, stat: Journal Article,

Overview of Taxol safety
Onetto, N; Canetta, R; Winograd, B; Catane, R; Dougan, M; Grechko, J; Burroughs, J; Rozencweig, M
1993 ;(15):131-139, Journal of the National Cancer Institute. Monographs
— id: 162344, year: 1993, vol: , page: 131, stat: Journal Article,

Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease
Schacter LP; Rozencweig M; Beltangady M; Allan JD; Canetta R; Cooley TP; Dolin R; Kelley S; Lambert J; Liebman HA; Messina M; Nicaise C; Seidlin M; Valentine FT; Yarchoan R; Smaldone LF
1992 Dec 15;80(12):2969-2976, Blood
— id: 42283, year: 1992, vol: 80, page: 2969, stat: Journal Article,

Drug discovery and development in the pharmaceutical industry
Schacter, L P; Anderson, C; Canetta, R M; Kelley, S; Nicaise, C; Onetto, N; Rozencweig, M; Smaldone, L; Winograd, B
1992 Dec;19(6):613-621, Seminars in oncology
— id: 162345, year: 1992, vol: 19, page: 613, stat: Journal Article,

Phase II study of tallysomycin S10b in patients with advanced colorectal cancer
Nicaise, C; Ajani, J; Goudeau, P; Rozencweig, M; Levin, B; Krakoff, I
1990 ;26(3):221-222, Cancer chemotherapy & pharmacology
— id: 162349, year: 1990, vol: 26, page: 221, stat: Journal Article,

Phase II study of tallysomycin S10b in patients with advanced head and neck cancer
Nicaise, C; Hong, W K; Dimery, W; Usakewicz, J; Rozencweig, M; Krakoff, I
1990 Aug;8(3):325-328, Investigational new drugs
— id: 162347, year: 1990, vol: 8, page: 325, stat: Journal Article,

Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patients
Rozencweig, M; McLaren, C; Beltangady, M; Ritter, J; Canetta, R; Schacter, L; Kelley, S; Nicaise, C; Smaldone, L; Dunkle, L
1990 Jul-Aug;12 Suppl 5:S570-S575, Reviews of infectious diseases
— id: 162348, year: 1990, vol: 12 Suppl 5, page: S570, stat: Journal Article,

Overview of hormonal therapy in advanced breast cancer
Schacter, L P; Rozencweig, M; Canetta, R; Kelley, S; Nicaise, C; Smaldone, L
1990 Dec;17(6 Suppl 9):38-46, Seminars in oncology
— id: 162346, year: 1990, vol: 17, page: 38, stat: Journal Article,

Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay
Schroyens, W; Dodion, P; Rozencweig, M
1990 ;116(4):392-396, Journal of cancer research & clinical oncology
— id: 162350, year: 1990, vol: 116, page: 392, stat: Journal Article,

Resistance to platinum compounds: mechanisms and beyond
Kelley, S L; Rozencweig, M
1989 Aug;25(8):1135-1140, European journal of cancer & clinical oncology
— id: 162351, year: 1989, vol: 25, page: 1135, stat: Journal Article,

Megestrol acetate: clinical experience
Schacter, L; Rozencweig, M; Canetta, R; Kelley, S; Nicaise, C; Smaldone, L
1989 Mar;16(1):49-63, Cancer treatment reviews
— id: 162352, year: 1989, vol: 16, page: 49, stat: Journal Article,

The EORTC Clonogenic Assay Screening Study Group (CASSG) program
Aapro, M S; Eliason, J F; Herman, C; Uitendaal, M; Rozencweig, M
1988 ;276:255-264, Progress in clinical & biological research
— id: 162357, year: 1988, vol: 276, page: 255, stat: Journal Article,

Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial
Bleiberg, H; Gerard, B; Dalesio, O; Crespeigne, N; Rozencweig, M
1988 ;22(4):316-320, Cancer chemotherapy & pharmacology
— id: 162356, year: 1988, vol: 22, page: 316, stat: Journal Article,

Carboplatin: current status and future prospects
Canetta, R; Bragman, K; Smaldone, L; Rozencweig, M
1988 Jun;15 Suppl B:17-32, Cancer treatment reviews
— id: 162355, year: 1988, vol: 15 Suppl B, page: 17, stat: Journal Article,

Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assay
Schroyens, W A; Meeker, J B; Dodion, P; Stryckmans, P A; Rozencweig, M
1988 Aug;24(8):1309-1312, European journal of cancer & clinical oncology
— id: 162354, year: 1988, vol: 24, page: 1309, stat: Journal Article,

Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A Phase II Study of the EORTC Malignant Melanoma Cooperative Group
Verschraegen, C F; Kleeberg, U R; Mulder, J; Rumke, P; Truchetet, F; Czarnetzki, B; Rozencweig, M; Thomas, D; Suciu, S
1988 Sep;62(6):1061-1065, Cancer
— id: 162353, year: 1988, vol: 62, page: 1061, stat: Journal Article,

Clinical status of carboplatin
Canetta, R; Franks, C; Smaldone, L; Bragman, K; Rozencweig, M
1987 Jul;1(5):61-70, Oncology
— id: 162361, year: 1987, vol: 1, page: 61, stat: Journal Article,

Sensitivity of normal human bone marrow myeloid progenitor cells to anthracycline, cisplatin, anthracene and flavone acetic acid derivatives, and its relevance for the prediction of human plasma concentrations of anticancer drugs
Dodion, P; Bron, D; Mattelaer, M A; Loos, M; Delforge, A; Rozencweig, M; Stryckmans, P; Kenis, Y
1987 Dec;23(12):1901-1908, European journal of cancer & clinical oncology
— id: 162360, year: 1987, vol: 23, page: 1901, stat: Journal Article,

Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells in vitro
Dodion, P; Sanders, C; Rombaut, W; Mattelaer, M A; Rozencweig, M; Stryckmans, P; Kenis, Y
1987 Dec;23(12):1909-1914, European journal of cancer & clinical oncology
— id: 162359, year: 1987, vol: 23, page: 1909, stat: Journal Article,

Clinical evaluation of anti-tumor therapy
Muggia, Franco M.; Rozencweig, Marcel
Boston : Nijhoff, 1987,
— id: 48, year: 1987, vol: , page: , stat: ,

Validation of the clinical predictive values of the in vitro phase II clonogenic assay in cancer of the breast and ovary
Staquet, M; Brown, B W Jr; Rozencweig, M; Van Muylder, E; Dodion, P; Sanders, C
1987 Dec;10(6):485-490, American journal of clinical oncology
— id: 162358, year: 1987, vol: 10, page: 485, stat: Journal Article,

Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanoma
Alberto, P; Rozencweig, M; Clavel, M; Siegenthaler, P; Cavalli, F; Gundersen, S; Bruntsch, U; Renard, J; Pinedo, H
1986 ;16(1):78-79, Cancer chemotherapy & pharmacology
— id: 162365, year: 1986, vol: 16, page: 78, stat: Journal Article,

Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivatives
Bron, D; Dodion, P; Rozencweig, M; Delforge, A; Mattelaer, M A; Kenis, Y; Stryckmans, P
1986 ;4(1):11-16, Investigational new drugs
— id: 162366, year: 1986, vol: 4, page: 11, stat: Journal Article,

Phase II study of a combination of hydroxyurea, fluorouracil and mitomycin in previously treated squamous cell carcinoma of the head and neck
Dodion, P; Cognetti, F; van Rymenant, M; Dalesio, O; Kirkpatrick, A; Rozencweig, M
1986 Mar;22(3):241-243, European journal of cancer & clinical oncology
— id: 162363, year: 1986, vol: 22, page: 241, stat: Journal Article,

Phase I study of oral idarubicin given with a weekly schedule
Dodion, P; Finet, C; Crespeigne, N; Beer, M; Nicaise, C; Rozencweig, M; Kenis, Y
1986 ;4(1):31-38, Investigational new drugs
— id: 162367, year: 1986, vol: 4, page: 31, stat: Journal Article,

In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assay
Dodion, P; Sanders, C; Rombaut, W; Rozencweig, M; Kitt, M M; Kenis, Y; Klastersky, J
1986 Mar;22(3):245-249, European journal of cancer & clinical oncology
— id: 162364, year: 1986, vol: 22, page: 245, stat: Journal Article,

Phase I study of triglycidylurazol given on a 5-day i.v. schedule
Nicaise, C; Rozencweig, M; Crespeigne, N; Dodion, P; Gerard, B; Lambert, M; Decoster, G; Kenis, Y
1986 May;70(5):599-603, Cancer treatment reports
— id: 162362, year: 1986, vol: 70, page: 599, stat: Journal Article,

Carboplatin: the clinical spectrum to date
Canetta, R; Rozencweig, M; Carter, S K
1985 Sep;12 Suppl A:125-136, Cancer treatment reviews
— id: 162371, year: 1985, vol: 12 Suppl A, page: 125, stat: Journal Article,

Carboplatin: future directions
Carter, S K; Canetta, R; Rozencweig, M
1985 Sep;12 Suppl A:145-152, Cancer treatment reviews
— id: 162369, year: 1985, vol: 12 Suppl A, page: 145, stat: Journal Article,

Phase II evaluation of bisantrene in metastatic breast cancer
Cavalli, F; Gerard, B; ten Bokkel Huinink, W; Clavel, M; Rozencweig, M
1985 Mar;69(3):337-338, Cancer treatment reports
— id: 162373, year: 1985, vol: 69, page: 337, stat: Journal Article,

Phase I-II evaluation of carminomycin in adults with acute leukemia
Debusscher, L; Malarme, M; Bron, D; Rozencweig, M; Stryckmans, P
1985 Jan;21(1):31-34, European journal of cancer & clinical oncology
— id: 162376, year: 1985, vol: 21, page: 31, stat: Journal Article,

Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin)
Dodion, P; Davis, T A; Rozencweig, M; Crespeigne, N; Kenis, Y; Bachur, N R
1985 ;3(4):361-368, Investigational new drugs
— id: 162377, year: 1985, vol: 3, page: 361, stat: Journal Article,

Human pharmacokinetics of marcellomycin
Dodion, P; Rozencweig, M; Nicaise, C; Watthieu, M; Tamburini, J M; Riggs, C E Jr; Bachur, N R
1985 ;14(1):42-48, Cancer chemotherapy & pharmacology
— id: 162375, year: 1985, vol: 14, page: 42, stat: Journal Article,

Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC)
Holdener, E E; Hansen, H H; Host, H; Bruntsch, U; Cavalli, F; Renard, J; Pinedo, H M; Rozencweig, M
1985 ;3(1):63-66, Investigational new drugs
— id: 162378, year: 1985, vol: 3, page: 63, stat: Journal Article,

Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC Breast Cancer Cooperative Group
Paridaens, R; Clarysse, A; Rozencweig, M; Rotmensz, N; Heuson, J C
1985 May;21(5):595-599, European journal of cancer & clinical oncology
— id: 162372, year: 1985, vol: 21, page: 595, stat: Journal Article,

Carboplatin: the clinical evaluation strategy
Rozencweig, M; Canetta, R; Carter, S K
1985 Sep;12 Suppl A:137-144, Cancer treatment reviews
— id: 162370, year: 1985, vol: 12 Suppl A, page: 137, stat: Journal Article,

Phase II study of ametantrone in a human tumor cloning assay
Rozencweig, M; Sanders, C; Rombaut, W; Crespeigne, N; Kenis, Y; Klastersky, J
1985 Feb;21(2):195-198, European journal of cancer & clinical oncology
— id: 162374, year: 1985, vol: 21, page: 195, stat: Journal Article,

Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: reply to a commentary
Staquet, M J; Byar, D P; Green, S B; Rozencweig, M
1985 Nov;69(11):1339-1340, Cancer treatment reports
— id: 162368, year: 1985, vol: 69, page: 1339, stat: Journal Article,

Phase II study of 9-hydroxy-2N-methylellipticinium acetate
Clarysse, A; Brugarolas, A; Siegenthaler, P; Abele, R; Cavalli, F; de Jager, R; Renard, G; Rozencweig, M; Hansen, H H
1984 Feb;20(2):243-247, European journal of cancer & clinical oncology
— id: 162384, year: 1984, vol: 20, page: 243, stat: Journal Article,

Phase II trial of diaziquone in advanced renal adenocarcinoma
Hansen, M; Gallmeier, W M; Vermorken, J; Holdener, E; Hansen, H H; Renard, J; Rozencweig, M
1984 Jul-Aug;68(7-8):1055-1056, Cancer treatment reports
— id: 162380, year: 1984, vol: 68, page: 1055, stat: Journal Article,

Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung
Joss, R A; Hansen, H H; Hansen, M; Renard, J; Rozencweig, M
1984 Apr;20(4):495-499, European journal of cancer & clinical oncology
— id: 162382, year: 1984, vol: 20, page: 495, stat: Journal Article,

Chemotherapy principles in the treatment of prostatic cancer
Konyves, I; Muntzing, J; Rozencweig, M
1984 ;5(1):55-62, Prostate
— id: 162387, year: 1984, vol: 5, page: 55, stat: Journal Article,

Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck
Rozencweig, M; Dodion, P; Bruntsch, U; Gallmeier, W; Clavel, M; Gignoux, B; Cortes Funes, H; Cavalli, F; Kirkpatrick, A; Dalesio, O
1984 Oct;54(8):1499-1503, Cancer
— id: 162379, year: 1984, vol: 54, page: 1499, stat: Journal Article,

In vitro growth of human malignancies in a cloning assay
Rozencweig, M; Hofmann, V; Sanders, C; Rombaut, W; Fruh, U; Martz, G
1984 ;94:1-7, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 162388, year: 1984, vol: 94, page: 1, stat: Journal Article,

Phase II study of carminomycin in a human tumor cloning assay
Rozencweig, M; Sanders, C; Rombaut, W; Crespeigne, N; Decoster, G; Kenis, Y; Klastersky, J
1984 ;2(3):267-270, Investigational new drugs
— id: 162386, year: 1984, vol: 2, page: 267, stat: Journal Article,

[Clonogenic cultures of human tumors. Potentials and difficulties]
Rozencweig, M; Sanders, C; Rombaut, W; Kenis, Y; Klastersky, J; Decoster, G
1984 Feb;39(3):134-137, Revue medicale de Liege
— id: 162385, year: 1984, vol: 39, page: 134, stat: Journal Article,

Predictive tests and infrequent events in cancer chemotherapy
Rozencweig, M; Staquet, M
1984 ;94:174-183, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 162389, year: 1984, vol: 94, page: 174, stat: Journal Article,

Predictive tests for the response to cancer chemotherapy: limitations related to the prediction of rare events
Rozencweig, M; Staquet, M
1984 Apr;68(4):611-613, Cancer treatment reports
— id: 162381, year: 1984, vol: 68, page: 611, stat: Journal Article,

Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer
Rozencweig, M; ten Bokkel Huinink, W; Cavalli, F; Bruntsch, U; Dombernowsky, P; Host, H; Bramwell, V; Renard, G; Van Glabbeke, M; Decoster, G
1984 Apr;2(4):275-281, Journal of clinical oncology
— id: 162383, year: 1984, vol: 2, page: 275, stat: Journal Article,

Phase II study of oral medroxyprogesterone acetate in advanced germ cell tumors
Cavalli, F; Klepp, O; Hansen, H; Rozencweig, M
1983 Oct;67(10):953-954, Cancer treatment reports
— id: 162390, year: 1983, vol: 67, page: 953, stat: Journal Article,

Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group
De Jager, R; Siegenthaler, P; Cavalli, F; Klepp, O; Bramwell, V; Joss, R; Alberto, P; van Glabbeke, M; Renard, J; Rozencweig, M; Hansen, H H
1983 Feb;19(2):289-293, European journal of cancer & clinical oncology
— id: 162399, year: 1983, vol: 19, page: 289, stat: Journal Article,

Phase II trial of diaziquone (AZQ) in advanced malignant melanoma
Host, H; Joss, R; Pinedo, H; Bruntsch, U; Cavalli, F; Renard, G; van Glabbeke, M; Rozencweig, M
1983 Feb;19(2):295-298, European journal of cancer & clinical oncology
— id: 162400, year: 1983, vol: 19, page: 295, stat: Journal Article,

[Chemotherapy of solid tumors. The role of cisplatin in today's chemotherapy]
Kenis, Y; Rozencweig, M; Sanders, C
1983 Apr;4(4):213-217, Revue medicale de Bruxelles
— id: 162396, year: 1983, vol: 4, page: 213, stat: Journal Article,

Clinical phase I trial of marcellomycin with a single-dose schedule
Nicaise, C; Rozencweig, M; de Marneffe, M; Crespeigne, N; Dodion, P; Piccart, M; Sculier, J P; Lenaz, L; Kenis, Y
1983 Apr;19(4):449-454, European journal of cancer & clinical oncology
— id: 162395, year: 1983, vol: 19, page: 449, stat: Journal Article,

[Phase I study of alizapride in cancer patients treated with cisplatin]
Nicaise, C; Rozencweig, M; Ortmans, M; Frisque, C; Bleiberg, H
1983 Sep;59(31):2161-2165, Gender & Psychoanalysis
— id: 162392, year: 1983, vol: 59, page: 2161, stat: Journal Article,

[In vitro determination of the antitumor activity of chemotherapy]
Piccart, M; Rozencweig, M
1983 Mar;4(3):147-149, Revue medicale de Bruxelles
— id: 162397, year: 1983, vol: 4, page: 147, stat: Journal Article,

Phase I trial with 4'-deoxydoxorubicin (esorubicin)
Rozencweig, M; Crespeigne, N; Kenis, Y
1983 ;1(4):309-313, Investigational new drugs
— id: 162401, year: 1983, vol: 1, page: 309, stat: Journal Article,

Phase I study of carboplatin given on a five-day intravenous schedule
Rozencweig, M; Nicaise, C; Beer, M; Crespeigne, N; Van Rijmenant, M; Lenaz, L; Kenis, Y
1983 Oct;1(10):621-626, Journal of clinical oncology
— id: 162391, year: 1983, vol: 1, page: 621, stat: Journal Article,

EORTC phase II trial of vindesine in advanced melanoma
Rumke, P; Everall, J D; Mulder, J H; Rozencweig, M; Czarnetzki, B; Thomas, D
1983 Aug;19(8):1173-1174, European journal of cancer & clinical oncology
— id: 162394, year: 1983, vol: 19, page: 1173, stat: Journal Article,

Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: rationale for a three-stage strategy
Staquet, M J; Byar, D P; Green, S B; Rozencweig, M
1983 Sep;67(9):753-765, Cancer treatment reports
— id: 162393, year: 1983, vol: 67, page: 753, stat: Journal Article,

[Preliminary study of a combination of fluorouracil and cisplatin in the treatment of tumors of the colon]
Vanderlinden, B; Rozencweig, M; Piccart, M; Nicaise, C; Van Rijmenant, M; Crespeigne, N; Kenis, Y
1983 Mar;4(3):139-143, Revue medicale de Bruxelles
— id: 162398, year: 1983, vol: 4, page: 139, stat: Journal Article,

Combination of dacarbazine and mitomycin in advanced colorectal cancer
Bleiberg, H; Clavel, M; Nicaise, C; Devriendt, J; Michel, J; Vanderlinden, B; Rozencweig, M
1982 Dec;10(1):68-69, Cancer chemotherapy & pharmacology
— id: 162402, year: 1982, vol: 10, page: 68, stat: Journal Article,

N-(phosphonacetyl)-L-aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC soft tissue sarcoma group
Bramwell, V; Van Oosterom, A; Mouridsen, H T; Cheix, F; Somers, R; Thomas, D; Rozencweig, M
1982 Jan;18(1):81-84, European journal of cancer & clinical oncology
— id: 162408, year: 1982, vol: 18, page: 81, stat: Journal Article,

Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. schedule
Dodion, P; Rozencweig, M; Nicaise, C; Piccart, M; Cumps, E; Crespeigne, N; Kisner, D; Kenis, Y
1982 Jun;18(6):519-522, European journal of cancer & clinical oncology
— id: 162405, year: 1982, vol: 18, page: 519, stat: Journal Article,

N-(phosphonacetyl)-L-aspartate (PALA) in advanced malignant melanoma: a phase II trial of the EORTC Malignant Melanoma Cooperative Group
Kleeberg, U R; Mulder, J H; Rumke, P; Thomas, D; Rozencweig, M
1982 Aug;18(8):723-726, European journal of cancer & clinical oncology
— id: 162404, year: 1982, vol: 18, page: 723, stat: Journal Article,

Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study
Mulder, J H; Dodion, P; Cavalli, F; Czarnetzki, B; Clavel, M; Thomas, D; Suciu, S; Rozencweig, M
1982 Dec;18(12):1297-1301, European journal of cancer & clinical oncology
— id: 162403, year: 1982, vol: 18, page: 1297, stat: Journal Article,

N-(phosphonacetyl)-L-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative group
Paridaens, R; Mouridsen, H T; Palshof, T; Cocconi, G; Van Oosterom, A; Rotmensz, N; Sylvester, R; Heuson, J C; Rozencweig, M
1982 Jan;18(1):67-70, European journal of cancer & clinical oncology
— id: 162409, year: 1982, vol: 18, page: 67, stat: Journal Article,

[Clonogenic cultures of human tumours. Experience and prospects in cancer chemotherapy (author's transl)]
Rozencweig, M; Makaroff, O; Prevost, J M; Kenis, Y; Klastersky, J
1982 Mar;11(14):1071-1074, La nouvelle presse medicale
— id: 162406, year: 1982, vol: 11, page: 1071, stat: Journal Article,

The cardiotoxicity of anticancer agents
Von Hoff, D D; Rozencweig, M; Piccart, M
1982 Mar;9(1):23-33, Seminars in oncology
— id: 162407, year: 1982, vol: 9, page: 23, stat: Journal Article,

[Anticancer therapy of carcinoid tumours (author's transl)]
Bleiberg, H; Rozencweig, M; Kenis, Y
1981 Mar-Apr;44(3-4):145-152, Acta gastro-enterologica Belgica
— id: 162416, year: 1981, vol: 44, page: 145, stat: Journal Article,

Phase II trial with chlorozotocin in advanced colorectal cancer
Bleiberg, H; Rozencweig, M; Michel, J; Clavel, M; Longeval, E; Feremans, W; Bondue, H; Lardinois, J; Crespeigne, N; Kenis, Y
1981 Aug;17(8):863-866, European journal of cancer & clinical oncology
— id: 162413, year: 1981, vol: 17, page: 863, stat: Journal Article,

Phase I clinical trial with a combination of methotrexate and mitomycin C
Body, J J; Rozencweig, M; Kenis, Y
1981 ;6(2):197-198, Cancer chemotherapy & pharmacology
— id: 162417, year: 1981, vol: 6, page: 197, stat: Journal Article,

Phase II study of oral VP-16-213 in hepatocellular carcinoma
Cavalli, F; Rozencweig, M; Renard, J; Goldhirsch, A; Hansen, H H
1981 Oct;17(10):1079-1082, European journal of cancer & clinical oncology
— id: 162412, year: 1981, vol: 17, page: 1079, stat: Journal Article,

Clinical trials with the hexitol derivatives in the U.S
Chiuten, D F; Rozencweig, M; Von Hoff, D D; Muggia, F M
1981 Feb;47(3):442-451, Cancer
— id: 161405, year: 1981, vol: 47, page: 442, stat: Journal Article,

Absorption of m-AMSA and its biliary metabolites from the rat small intestine
Gormley, P E; Shoemaker, D; Rozencweig, M; Ayers, O C; Cysyk, R L
1981 Oct;17(10):1143-1146, European journal of cancer & clinical oncology
— id: 162411, year: 1981, vol: 17, page: 1143, stat: Journal Article,

Phase I clinical trial with ametantrone (NSC-287513)
Piccart, M; Rozencweig, M; Abele, R; Cumps, E; Dodion, P; Dupont, D; Kisner, D; Kenis, Y
1981 Jul;17(7):775-779, European journal of cancer & clinical oncology
— id: 162415, year: 1981, vol: 17, page: 775, stat: Journal Article,

Phase I clinical trial with alpha 1,3,5- triglycidyl-s-triazinetrione (NSC-296934)
Piccart, M; Rozencweig, M; Dodion, P; Cumps, E; Crespeigne, N; Makaroff, O; Atassi, G; Kisner, D; Kenis, Y
1981 Dec;17(12):1263-1266, European journal of cancer & clinical oncology
— id: 162410, year: 1981, vol: 17, page: 1263, stat: Journal Article,

Cisplatin: impact of a new anticancer agent on current therapeutic strategies
Rozencweig, M; Abele, R; von Hoff, D D; Muggia, F M
1981 ;1(4):199-204, Anticancer research
— id: 161408, year: 1981, vol: 1, page: 199, stat: Journal Article,

Animal toxicology for early clinical trials with anticancer agents
Rozencweig, M; Von Hoff, D D; Staquet, M J; Schein, P S; Penta, J S; Goldin, A; Muggia, F M; Freireich, E J; DeVita, V T Jr
1981 ;4(1):21-28, Cancer clinical trials
— id: 161409, year: 1981, vol: 4, page: 21, stat: Journal Article,

Clinical studies with a THC analog (BRL-4664) in the prevention of cisplatin-induced vomiting
Staquet, M; Bron, D; Rozencweig, M; Kenis, Y
1981 Aug-Sep;21(8-9 Suppl):60S-63S, Journal of clinical pharmacology
— id: 162414, year: 1981, vol: 21, page: 60S, stat: Journal Article,

Methodology for the assessment of new dichotomous diagnostic tests
Staquet, M; Rozencweig, M; Lee, Y J; Muggia, F M
1981 ;34(12):599-610, Journal of chronic diseases
— id: 161410, year: 1981, vol: 34, page: 599, stat: Journal Article,

[Chemotherapy of non-seminoma tumours of the testis (author's transl)]
Abele, R; Rozencweig, M
1980 Nov;9(45):3449-3454, La nouvelle presse medicale
— id: 162419, year: 1980, vol: 9, page: 3449, stat: Journal Article,

Carminomycin (NSC-180024): a phase I study
Abele, R; Rozencweig, M; Body, J J; Bedogni, P; Reich, S D; Crooke, S T; Lenaz, L; Kenis, Y
1980 Dec;16(12):1555-1559, European journal of cancer
— id: 162418, year: 1980, vol: 16, page: 1555, stat: Journal Article,

Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trial
Hayat, M; Brule, G; Cappelaere, P; Cattan, A; Chauvergne, J; Clavel, B; Guerrin, J; Misset, J L; Pommatau, E; Ribaud, P; Muggia, F M; Rozencweig, M; Mathe, G
1980 ;74:139-145, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161428, year: 1980, vol: 74, page: 139, stat: Journal Article,

[Treatment of various stages of Hodgkin's disease (author's transl)]
Kenis, Y; Abele, M; Rozencweig, M
1980 May;1(5):299-305, Revue medicale de Bruxelles
— id: 162420, year: 1980, vol: 1, page: 299, stat: Journal Article,

Long-term survivors with small cell carcinoma of the lung
Matthews, M J; Rozencweig, M; Staquet, M J; Minna, J D; Muggia, F M
1980 Apr;16(4):527-531, European journal of cancer
— id: 161416, year: 1980, vol: 16, page: 527, stat: Journal Article,

Phase II trials: use of a clinical tumor panel and overview of current resources and studies
Muggia, F M; Rozencweig, M; Chiuten, D F; Jensen-Akula, M S; Charles, L M Jr; Kubota, T T; Bono, V H Jr
1980 Jan;64(1):1-9, Cancer treatment reports
— id: 161419, year: 1980, vol: 64, page: 1, stat: Journal Article,

Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced disease
Muggia, F M; Rozencweig, M; Louie, A E
1980 Jan-Feb;2(3):196-205, Head & neck surgery
— id: 161421, year: 1980, vol: 2, page: 196, stat: Journal Article,

Clinical implications of cisplatin pharmacology
Muggia, F M; Rozencweig, M; Penta, J
1980 ;74:132-138, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161429, year: 1980, vol: 74, page: 132, stat: Journal Article,

Methodology phase II clinical trial in cancer
Muggia, F M; Rozencweig, M; Staquet, M J; McGuire, W P Jr
1980 ;70:53-60, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161425, year: 1980, vol: 70, page: 53, stat: Journal Article,

ROLE OF CHEMOTHERAPY IN HEAD AND NECK-CANCER - SYSTEMIC USE OF SINGLE AGENTS AND COMBINATIONS IN ADVANCED DISEASE
Muggia, FM; Rozencweig, M; Louie, AE
1980 ;2(3):196-205, Head & neck surgery
— id: 27934, year: 1980, vol: 2, page: 196, stat: Journal Article,

[New drugs in cancer chemotherapy (author's transl)]
Rozencweig, M; Abele, R; Bedogni, P; Kenis, Y
1980 May;1(5):325-329, Revue medicale de Bruxelles
— id: 162421, year: 1980, vol: 1, page: 325, stat: Journal Article,

N-(Phosphonacetyl)-L-aspartate (PALA): current status
Rozencweig, M; Abele, R; Piccart, M; Von Hoff, D D; Muggia, F M
1980 ;74:72-77, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161422, year: 1980, vol: 74, page: 72, stat: Journal Article,

Surgical adjuvant trials in the United States
Rozencweig, M; Von Hoff, D D; Allegra, J C; Muggia, F M
1980 ;Suppl 1:173-177, European journal of cancer
— id: 161420, year: 1980, vol: Suppl 1, page: 173, stat: Journal Article,

m-AMSA: a new anticancer agent
Rozencweig, M; Von Hoff, D D; Legha, S S; Cysyk, R L; Muggia, F M
1980 ;74:250-257, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161432, year: 1980, vol: 74, page: 250, stat: Journal Article,

International activities of the Division of Cancer Treatment, National Cancer Institute
Goldin, A; Muggia, F M; Rozencweig, M
1979 Spring;2(1):29-35, Cancer clinical trials
— id: 161450, year: 1979, vol: 2, page: 29, stat: Journal Article,

Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents
Guarino, A M; Rozencweig, M; Kline, I; Penta, J S; Venditti, J M; Lloyd, H H; Holzworth, D A; Muggia, F M
1979 Jun;39(6 Pt 1):2204-2210, Cancer research
— id: 161444, year: 1979, vol: 39, page: 2204, stat: Journal Article,

Chemotherapy of testicular cancer: from palliation to curative adjuvant therapy
Jacobs, E M; Muggia, F M; Rozencweig, M
1979 Mar;6(1):3-13, Seminars in oncology
— id: 161451, year: 1979, vol: 6, page: 3, stat: Journal Article,

Analysis and interpretation of response rates for anticancer drugs
Lee, Y J; Catane, R; Rozencweig, M; Bono, V H Jr; Muggia, F M; Simon, R; Staquet, M J
1979 Nov-Dec;63(11-12):1713-1720, Cancer treatment reports
— id: 161435, year: 1979, vol: 63, page: 1713, stat: Journal Article,

Lung cancer : progress in therapeutic research
Muggia, Franco M.; Rozencweig, Marcel
New York : Raven Press, 1979,
— id: 172, year: 1979, vol: , page: , stat: ,

Mouse and large-animal toxicology studies of twelve antitumor agents: relevance to starting dose for phase I clinical trials
Penta, J S; Rozencweig, M; Guarino, A M; Muggia, F M
1979 ;3(2):97-101, Cancer chemotherapy & pharmacology
— id: 161453, year: 1979, vol: 3, page: 97, stat: Journal Article,

Anthracycline derivatives in new drug development programs
Rozencweig, M; De Sloover, C; Von Hoff, D D; Tagnon, H J; Muggia, F M
1979 May;63(5):807-808, Cancer treatment reports
— id: 161449, year: 1979, vol: 63, page: 807, stat: Journal Article,

m-AMSA and PALA: two new agents in cancer chemotherapy
Rozencweig, M; Von Hoff, D D; Cysyk, R L; Muggia, F M
1979 ;3(3):135-141, Cancer chemotherapy & pharmacology
— id: 161452, year: 1979, vol: 3, page: 135, stat: Journal Article,

The delta and epsilon errors in the assessment of cancer clinical trials
Staquet, M J; Rozencweig, M; Von Hoff, D D; Muggia, F M
1979 Nov-Dec;63(11-12):1917-1921, Cancer treatment reports
— id: 161434, year: 1979, vol: 63, page: 1917, stat: Journal Article,

Risk factors for doxorubicin-induced congestive heart failure
Von Hoff, D D; Layard, M W; Basa, P; Davis, H L Jr; Von Hoff, A L; Rozencweig, M; Muggia, F M
1979 Nov;91(5):710-717, Annals of internal medicine
— id: 161433, year: 1979, vol: 91, page: 710, stat: Journal Article,

cis-Diamminedichloroplatinum(II): a metal complex with significant anticancer activity
Von Hoff, D D; Rozencweig, M
1979 ;16:273-298, Advances in pharmacology & chemotherapy
— id: 162422, year: 1979, vol: 16, page: 273, stat: Journal Article,

The evaluation of cytotoxic drugs
Von Hoff, D D; Rozencweig, M; Muggia, F M
1979 Jun;6 Suppl:1-8, Cancer treatment reviews
— id: 161447, year: 1979, vol: 6 Suppl, page: 1, stat: Journal Article,

Toxic effects of cis-dichlorodiammineplatinum(II) in man
Von Hoff, D D; Schilsky, R; Reichert, C M; Reddick, R L; Rozencweig, M; Young, R C; Muggia, F M
1979 Sep-Oct;63(9-10):1527-1531, Cancer treatment reports
— id: 161438, year: 1979, vol: 63, page: 1527, stat: Journal Article,

Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial cooperative group
Alberto, P; Rozencweig, M; Gangji, D; Brugarolas, A; Cavalli, F; Siegenthaler, P; Hansen, H H; Sylvester, R
1978 Feb;14(2):195-201, European journal of cancer
— id: 162424, year: 1978, vol: 14, page: 195, stat: Journal Article,

The use of peritoneoscopy in the detection of liver metastases
Bleiberg, H; Rozencweig, M; Mathieu, M; Beyens, M; Gompel, C; Gerard, A
1978 Mar;41(3):863-867, Cancer
— id: 162423, year: 1978, vol: 41, page: 863, stat: Journal Article,

Role of antitumor antibiotics in current oncologic practice
Davis, H L Jr; von Hoff, D D; Henney, J E; Rozencweig, M
1978 ;63:21-29, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 162428, year: 1978, vol: 63, page: 21, stat: Journal Article,

The role of antitumor antibiotics in current oncologic practice
Davis, H L Jr; von Hoff, D D; Henney, J E; Rozencweig, M
1978 ;1(2):83-90, Cancer chemotherapy & pharmacology
— id: 162426, year: 1978, vol: 1, page: 83, stat: Journal Article,

The chemotherapy of Hodgkin's disease: past experiences and future directions
DeVita, V T Jr; Lewis, B J; Rozencweig, M; Muggia, F M
1978 Aug;42(2 Suppl):979-990, Cancer
— id: 161459, year: 1978, vol: 42, page: 979, stat: Journal Article,

Effective adjuvant treatments. A brief review of U.S. clinical trials
Louie, A C; Rozencweig, M; von Hoff, D D; Muggia, F M
1978 ;48(7):653-658, Archiv fur Geschwulstforschung
— id: 161471, year: 1978, vol: 48, page: 653, stat: Journal Article,

Adjuvant systemic therapy of cancer: rationale for future trials
Muggia, F M; Rozencweig, M
1978 ;68:431-438, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161476, year: 1978, vol: 68, page: 431, stat: Journal Article,

Double-blind crossover clinical pharmacology study comparing moxestrol (R 2858) and ethinyl estradiol in postmenopausal women
Robyn, C; Vekemans, M; Rozencweig, M; Chigot, D; Raynaud, J P
1978 Jan;18(1):29-34, Journal of clinical pharmacology
— id: 162427, year: 1978, vol: 18, page: 29, stat: Journal Article,

Current trends and prospects in surgical adjuvant trials
Rozencweig, M; von Hoff, D D; Louie, A C; Muggia, F M
1978 ;48(7):673-679, Archiv fur Geschwulstforschung
— id: 161470, year: 1978, vol: 48, page: 673, stat: Journal Article,

Sounding board. Waiting for a bus: Does it explain age-dependent differences in response to chemotherapy of early breast cancer?
Rozencweig, M; Zelen, M; Von Hoff, D D; Muggia, F M
1978 Dec;299(24):1363-1364, New England journal of medicine
— id: 161456, year: 1978, vol: 299, page: 1363, stat: Journal Article,

"Single"-agent activity of high-dose methotrexate with citrovorum factor rescue
Von Hoff, D D; Rozencweig, M; Louie, A C; Bender, R A; Muggia, F M
1978 Feb;62(2):233-235, Cancer treatment reports
— id: 161464, year: 1978, vol: 62, page: 233, stat: Journal Article,

Daunomycin: an anthracycline antibiotic effective in acute leukemia
Von Hoff, D D; Rozencweig, M; Slavik, M
1978 ;15:1-50, Advances in pharmacology & chemotherapy
— id: 162425, year: 1978, vol: 15, page: 1, stat: Journal Article,

ICRF-159: current status and clinical prospects
Bellet, R E; Rozencweig, M; Von Hoff, D D; Penta, J S; Wasserman, T H; Muggia, F M
1977 Nov;13(11):1293-1298, European journal of cancer
— id: 161483, year: 1977, vol: 13, page: 1293, stat: Journal Article,

Peritoneoscopy as a diagnostic supplement to liver function tests and liver scan in patients with carcinoma
Bleiberg, H; Rozencweig, M; Longeval, E; Fruhling, J; de Maertelaer, V
1977 Dec;145(6):821-825, Surgery, gynecology & obstetrics
— id: 162429, year: 1977, vol: 145, page: 821, stat: Journal Article,

Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment
Borkowski, A; L'hermite, M; Dor, P; Longeval, E; Rozencweig, M; Muquardt, C; Van Cauter, E
1977 May;73(2):235-246, Journal of endocrinology
— id: 162430, year: 1977, vol: 73, page: 235, stat: Journal Article,

Adjuvant chemotherapy: correct advice
Louie, A; Von Hoff, D D; Rozencweig, M; Muggia, F
1977 Apr;237(16):1691-1691, JAMA
— id: 161279, year: 1977, vol: 237, page: 1691, stat: Journal Article,

Tuftsin - unimportant or forgotten
Mikulski, S W; Von Hoff, D D; Rozencweig, M; Muggia, F M
1977 Feb;296(8):454-454, New England journal of medicine
— id: 161496, year: 1977, vol: 296, page: 454, stat: Journal Article,

Current cooperative clinical trials in the non-Hodgkin's lymphomas
Muggia, F M; Davis, H L Jr; Rozencweig, M
1977 Sep;61(6):1191-1197, Cancer treatment reports
— id: 161485, year: 1977, vol: 61, page: 1191, stat: Journal Article,

VM 26 and VP 16-213: a comparative analysis
Rozencweig, M; Von Hoff, D D; Henney, J E; Muggia, F M
1977 Jul;40(1):334-342, Cancer
— id: 161489, year: 1977, vol: 40, page: 334, stat: Journal Article,

Investigational chemotherapeutic agents in head and neck cancer
Rozencweig, M; Von Hoff, D D; Muggia, F M
1977 Dec;4(4):425-429, Seminars in oncology
— id: 161480, year: 1977, vol: 4, page: 425, stat: Journal Article,

Cis-diamminedichloroplatinum (II). A new anticancer drug
Rozencweig, M; von Hoff, D D; Slavik, M; Muggia, F M
1977 Jun;86(6):803-812, Annals of internal medicine
— id: 161491, year: 1977, vol: 86, page: 803, stat: Journal Article,

Pharmacokinetics of adriamycin and adriamycin--DNA complex in L1210 mice and men
Staquet, M; Rozencweig, M; Duarte-Karim, M; Kenis, Y
1977 Apr-May;13(4-5):433-435, European journal of cancer
— id: 162431, year: 1977, vol: 13, page: 433, stat: Journal Article,

Time relationship between last dose of daunorubicin and congestive heart failure
Von Hoff, D D; Layard, M; Rozencweig, M; Muggia, F M
1977 Oct;61(7):1411-1413, Cancer treatment reports
— id: 161484, year: 1977, vol: 61, page: 1411, stat: Journal Article,

Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases
Von Hoff, D D; Rozencweig, M; Layard, M; Slavik, M; Muggia, F M
1977 Feb;62(2):200-208, American journal of medicine
— id: 161498, year: 1977, vol: 62, page: 200, stat: Journal Article,

Cytembena: an anticancer drug with an unique structure
Von Hoff, D D; Rozencweig, M; Muggia, F M
1977 Dec;26(6):388-392, Biomedicine
— id: 161479, year: 1977, vol: 26, page: 388, stat: Journal Article,

Estramustine phosphate: a specific chemotherapeutic agent?
Von Hoff, D D; Rozencweig, M; Slavik, M; Muggia, F M
1977 Apr;117(4):464-466, Journal of urology
— id: 161494, year: 1977, vol: 117, page: 464, stat: Journal Article,

Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents
Von Hoff, D D; Rozencweig, M; Soper, W T; Helman, L J; Penta, J S; Davis, H L; Muggia, F M
1977 Aug;61(5):759-768, Cancer treatment reports
— id: 161487, year: 1977, vol: 61, page: 759, stat: Journal Article,

Peritoneoscopic evaluation of the effect of chemotherapeutic agents on liver metastases of breast cancer (report of 2 cases)
Bleiberg, H; Rozencweig, M; Gangii, D; Heuson, J C
1976 Nov;8(4):217-220, Endoscopy
— id: 162432, year: 1976, vol: 8, page: 217, stat: Journal Article,

Neocarzinostatin (NSC 157365) a new cancerostatic compound
Legha, S S; Von Hoff, D D; Rozencweig, M; Abraham, D; Slavik, M; Muggia, M
1976 ;33(5-6):265-270, Oncology (New York)
— id: 162435, year: 1976, vol: 33, page: 265, stat: Journal Article,

Overview of early and investigational chemotherapeutic agents in solid tumors
Rozencweig, M; Slavik, M; Muggia, F M; Carter, S K
1976 ;2(4):417-432, Medical & pediatric oncology
— id: 161506, year: 1976, vol: 2, page: 417, stat: Journal Article,

Antibacterial activity and pharmacokinetics of bacampicillin and ampicillin
Rozencweig, M; Staquet, M; Klastersky, J
1976 May;19(5 Pt 1):592-597, Clinical pharmacology & therapeutics
— id: 162433, year: 1976, vol: 19, page: 592, stat: Journal Article,

EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma
Schulman, C C; Rozencweig, M; Staquet, M; Kenis, Y; Sylvester, R
1976 ;2(6):271-273, European urology
— id: 162434, year: 1976, vol: 2, page: 271, stat: Journal Article,

Activity of daunomycin in solid tumors
Von Hoff, D D; Rozencweig, M; Slavik, M; Muggia, F M
1976 Oct;236(15):1693-1693, JAMA
— id: 161500, year: 1976, vol: 236, page: 1693, stat: Journal Article,

[Role of chemotherapy in the treatment of bronchopulmonary neoplasms]
Kenis, Y; Rozencweig, M
1975 Sep;55(9):463-471, Bruxelles medical
— id: 162438, year: 1975, vol: 55, page: 463, stat: Journal Article,

[The role of chemotherapy in the palliative and curative treatment of lung cancer (author's transl)]
Kenis, Y; Rozencweig, M
1975 Jul-Oct;66(4-5):368-379, Acta tuberculosea et pneumologica Belgica
— id: 162439, year: 1975, vol: 66, page: 368, stat: Journal Article,

Letter: Prolactin, levodopa, and migraine
Rozencweig, M; Heuson, J C
1975 Apr;1(7910):810-810, Lancet
— id: 162440, year: 1975, vol: 1, page: 810, stat: Journal Article,

[Present state and prospective views of the chemotherapy in tumours of the digestive tract (author's transl)]
Rozencweig, M; Kenis, Y; Bertrand, M; Bleiberg, H
1975 Sep-Oct;38(9-10):347-360, Acta gastro-enterologica Belgica
— id: 162436, year: 1975, vol: 38, page: 347, stat: Journal Article,

[Hodgkin's disease: a curable cancer]
Rozencweig, M; Kenis, Y; Goffin, J C; Mendes da Costa, P
1975 Sep;55(9):473-481, Bruxelles medical
— id: 162437, year: 1975, vol: 55, page: 473, stat: Journal Article,

[Cell proliferation and action of chemotherapy in malignant lymphomas of the lymphocytic type in the leukemic phase]
Stryckmans, P; Debusscher, L; Delalieux, G; Rozencweig, M
1975 ;30(4):290-297, Acta clinica Belgica
— id: 162441, year: 1975, vol: 30, page: 290, stat: Journal Article,

Letter: Breast cancer regression under oestrogen therapy
L'Hermite, M; Robyn, C; Heuson, J C; Rozencweig, M
1974 Mar;1(5904):390-390, British medical journal (1857-1980)
— id: 162442, year: 1974, vol: 1, page: 390, stat: Journal Article,

Effects of 2-Br-alpha-Ergocryptine, L-dopa and cyclic imides on serum prolactin in postmenopausal women
Rozencweig, M; Heuson, J C; Bila, S; L'Hermite, M; Robyn, C
1973 Sep;9(9):657-664, European journal of cancer
— id: 162443, year: 1973, vol: 9, page: 657, stat: Journal Article,